Details of the Drug Reposition

General Information of This Drug (ID: DMRGTZ2)

• Drug Name: SSTarbaclofen (DMRGTZ2)

Information on Drug Reposition of This Drug

2 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Autism spectrum disorder	DISXK8NV	6A02	Phase 2	[1]
Fragile X syndrome	DISE8W3A	LD55	Phase 2	[1]

References

• [1] ClinicalTrials.gov (NCT01288716) Study of Arbaclofen for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders. U.S. National Institutes of Health.